Condoliase
- Generic Name
- Condoliase
- Drug Type
- Biotech
- CAS Number
- 9024-13-9
- Unique Ingredient Identifier
- 7SI2UZG934
- Background
Condoliase has been used in trials studying the treatment of Lumbar Disc Disease, Lumbar Vertebra Hernia, and Intervertebral Disc Disease.
SI-6603 (Condoliase) Study for Lumbar Disc Herniation (Discovery 6603 Study)
- First Posted Date
- 2018-07-31
- Last Posted Date
- 2024-04-18
- Lead Sponsor
- Seikagaku Corporation
- Target Recruit Count
- 352
- Registration Number
- NCT03607838
- Locations
- ๐บ๐ธ
Indiana Spine Group, Carmel, Indiana, United States
๐บ๐ธHRMD Research, Dallas, Texas, United States
๐บ๐ธGershon Pain Specialists, Virginia Beach, Virginia, United States
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Phase 3
Completed
- Conditions
- Intervertebral Disc DiseaseLumbar Disc Disease
- Interventions
- First Posted Date
- 2015-04-20
- Last Posted Date
- 2023-03-23
- Lead Sponsor
- Seikagaku Corporation
- Target Recruit Count
- 1011
- Registration Number
- NCT02421601
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Phase 3
Completed
- Conditions
- Intervertebral Disc DiseaseLumbar Disc Disease
- Interventions
- Drug: placebo
- First Posted Date
- 2013-09-13
- Last Posted Date
- 2023-03-23
- Lead Sponsor
- Seikagaku Corporation
- Target Recruit Count
- 385
- Registration Number
- NCT01941563
Clinical Trial to Assess Safety of SI-6603 in Patients With Lumbar Disc Herniation
- First Posted Date
- 2011-01-25
- Last Posted Date
- 2023-03-23
- Lead Sponsor
- Seikagaku Corporation
- Target Recruit Count
- 18
- Registration Number
- NCT01282606
- Locations
- ๐บ๐ธ
SKK, Encinitas, California, United States
SI-6603 Versus Placebo in Patients With Lumbar Disc Herniation
- First Posted Date
- 2008-03-13
- Last Posted Date
- 2023-03-23
- Lead Sponsor
- Seikagaku Corporation
- Target Recruit Count
- 195
- Registration Number
- NCT00634946
- Locations
- ๐ฏ๐ต
Chubu Area, Chubu, Japan
๐ฏ๐ตKansai Area, Kansai, Japan
๐ฏ๐ตChugoku Area, Chugoku, Japan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
ยฉ Copyright 2025. All Rights Reserved by MedPath